HOFFMAN ROBERT

President, CEO and Interim CFO at DelMar Pharmaceuticals, Inc. · on record since Nov 10, 2021
Director at FibroBiologics, Inc. · on record since Feb 7, 2024
Chief Financial Officer at CYTODYN INC · on record since May 22, 2025
Director at CombiMatrix Corp · on record since Jul 17, 2013
Director at Esperion Therapeutics, Inc. · on record since Jun 1, 2026
CHIEF FINANCIAL OFFICER at North Horizon, Inc. · on record since Nov 21, 2016
Director at TELIK INC · on record since Sep 12, 2014
Director at ZETA ACQUISITION CORP III · on record since Mar 26, 2015
VP, Finance & CAO at ARENA PHARMACEUTICALS INC · on record since Oct 4, 2004
CFO & SVP, Finance at AP PHARMA INC /DE/ · on record since Apr 24, 2017
Director at DelMar Pharmaceuticals, Inc. · on record since Apr 17, 2018
Director at Versartis, Inc. · on record since Oct 16, 2018
Former Director at Versartis, Inc. · on record since Apr 9, 2020

Insider trading activity of HOFFMAN ROBERT

Transactions on record: 123; since Oct 2, 2003

Open-market buys: 3; $65.8K

Open-market sells: 12; $2.4M

Companies traded: 11; last filing Jun 23, 2026

Figures computed from official regulatory filings — methodology.

Companies where HOFFMAN ROBERT has traded

FibroBiologics, Inc.3 tx · Jun 23, 2026
Esperion Therapeutics, Inc.4 tx · Jun 1, 2026
CYTODYN INC2 tx · Mar 24, 2026
DelMar Pharmaceuticals, Inc.17 tx · $25.9K · Feb 17, 2026
ZETA ACQUISITION CORP III7 tx · Jun 23, 2021
AP PHARMA INC /DE/10 tx · $1.6M · Dec 23, 2019
Versartis, Inc.5 tx · Sep 13, 2019
CombiMatrix Corp12 tx · $16K · Nov 16, 2017
TELIK INC12 tx · $299.6K · May 23, 2017
North Horizon, Inc.

Track record of HOFFMAN ROBERT

Statistical track record

Free

Open-market buys: 5

Last buy: Feb 15, 2022

Win rates and median returns are available with a free account (5 insiders/month).

Create a free account

Transaction history of HOFFMAN ROBERT

Co-insiders of HOFFMAN ROBERT

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Company	Filed	Type	Qty	Price	Value · USD	Src
FibroBiologics, Inc.	Jun 23, 2026	AwardD	30,803	0.00 USD	—	SEC
Esperion Therapeutics, Inc.	Jun 1, 2026	Award	79,873	0.00 USD	$0	SEC
CYTODYN INC	Mar 24, 2026	AwardD	4,874,691	0.00 USD	$0	SEC
DelMar Pharmaceuticals, Inc.	Feb 17, 2026	AwardD	156,240	0.00 USD	$0	SEC
FibroBiologics, Inc.	Jun 12, 2025	AwardD	22,000	0.00 USD	$0	SEC
Esperion Therapeutics, Inc.	Jun 2, 2025	AwardD	7,040	0.00 USD	$0	SEC
Esperion Therapeutics, Inc.	Jun 2, 2025	Award	5,280	0.00 USD	$0	SEC
CYTODYN INC	May 22, 2025	AwardD	1,000,000	0.00 USD	$0	SEC
Esperion Therapeutics, Inc.	Apr 2, 2025	AwardD	40,000	0.00 USD	$0	SEC
DelMar Pharmaceuticals, Inc.	Jan 6, 2025	AwardD	51,275	0.00 USD	$0	SEC
FibroBiologics, Inc.	Aug 27, 2024	AwardD	5,000	0.00 USD	$0	SEC
DelMar Pharmaceuticals, Inc.	Sep 1, 2023	AwardD	23,142	0.00 USD	$0	SEC
DelMar Pharmaceuticals, Inc.	Jun 2, 2023	Award	59,800	0.00 USD	$0	SEC
DelMar Pharmaceuticals, Inc.	Aug 3, 2022	AwardD	1,200,634	0.00 USD	$0	SEC
DelMar Pharmaceuticals, Inc.	Aug 3, 2022	Award	400,145	0.00 USD	$0	SEC
DelMar Pharmaceuticals, Inc.	Feb 17, 2022	Buy	55,000	0.47 USD	$25.9K	SEC
DelMar Pharmaceuticals, Inc.	Nov 10, 2021	AwardD	3,519,170	0.00 USD	$0	SEC
DelMar Pharmaceuticals, Inc.	Sep 22, 2021	AwardD	100,000	0.00 USD	$0	SEC
ZETA ACQUISITION CORP III	Jun 23, 2021	AwardD	23,000	0.00 USD	$0	SEC
DelMar Pharmaceuticals, Inc.	Sep 17, 2020	AwardD	120,000	0.00 USD	$0	SEC
DelMar Pharmaceuticals, Inc.	Jun 30, 2020	AwardD	39,567	0.00 USD	$0	SEC
ZETA ACQUISITION CORP III	Jun 26, 2020	AwardD	23,000	0.00 USD	$0	SEC
AP PHARMA INC /DE/	Dec 23, 2019	AwardD	100,000	0.00 USD	$0	SEC
Versartis, Inc.	Sep 13, 2019	AwardD	7,500	0.00 USD	$0	SEC
DelMar Pharmaceuticals, Inc.	Sep 9, 2019	AwardD	35,433	0.00 USD	$0	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
FibroBiologics, Inc.	Jun 23, 2026	AwardD	30,803	0.00 USD	—	SEC
Esperion Therapeutics, Inc.	Jun 1, 2026	Award	79,873	0.00 USD	$0	SEC
CYTODYN INC	Mar 24, 2026	AwardD	4,874,691	0.00 USD	$0	SEC
DelMar Pharmaceuticals, Inc.	Feb 17, 2026	AwardD	156,240	0.00 USD	$0	SEC
FibroBiologics, Inc.	Jun 12, 2025	AwardD	22,000	0.00 USD	$0	SEC
Esperion Therapeutics, Inc.	Jun 2, 2025	AwardD	7,040	0.00 USD	$0	SEC
Esperion Therapeutics, Inc.	Jun 2, 2025	Award	5,280	0.00 USD	$0	SEC
CYTODYN INC	May 22, 2025	AwardD	1,000,000	0.00 USD	$0	SEC
Esperion Therapeutics, Inc.	Apr 2, 2025	AwardD	40,000	0.00 USD	$0	SEC
DelMar Pharmaceuticals, Inc.	Jan 6, 2025	AwardD	51,275	0.00 USD	$0	SEC
FibroBiologics, Inc.	Aug 27, 2024	AwardD	5,000	0.00 USD	$0	SEC
DelMar Pharmaceuticals, Inc.	Sep 1, 2023	AwardD	23,142	0.00 USD	$0	SEC
DelMar Pharmaceuticals, Inc.	Jun 2, 2023	Award	59,800	0.00 USD	$0	SEC
DelMar Pharmaceuticals, Inc.	Aug 3, 2022	AwardD	1,200,634	0.00 USD	$0	SEC
DelMar Pharmaceuticals, Inc.	Aug 3, 2022	Award	400,145	0.00 USD	$0	SEC
DelMar Pharmaceuticals, Inc.	Feb 17, 2022	Buy	55,000	0.47 USD	$25.9K	SEC
DelMar Pharmaceuticals, Inc.	Nov 10, 2021	AwardD	3,519,170	0.00 USD	$0	SEC
DelMar Pharmaceuticals, Inc.	Sep 22, 2021	AwardD	100,000	0.00 USD	$0	SEC
ZETA ACQUISITION CORP III	Jun 23, 2021	AwardD	23,000	0.00 USD	$0	SEC
DelMar Pharmaceuticals, Inc.	Sep 17, 2020	AwardD	120,000	0.00 USD	$0	SEC
DelMar Pharmaceuticals, Inc.	Jun 30, 2020	AwardD	39,567	0.00 USD	$0	SEC
ZETA ACQUISITION CORP III	Jun 26, 2020	AwardD	23,000	0.00 USD	$0	SEC
AP PHARMA INC /DE/	Dec 23, 2019	AwardD	100,000	0.00 USD	$0	SEC
Versartis, Inc.	Sep 13, 2019	AwardD	7,500	0.00 USD	$0	SEC
DelMar Pharmaceuticals, Inc.	Sep 9, 2019	AwardD	35,433	0.00 USD	$0	SEC